Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM
- 1Department of Oncology, The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China
- 2The Medical Division, HaploX Biotechnology, Shenzhen, China
- 3Department of Gastroenterology, The Second Medical Center of the Chinese PLA General Hospital, Beijing, China
- 4Department of Radiotherapy, The Eighth Medical Center of the Chinese PLA General Hospital, Beijing, China
Citation: Wang X, Gong Y, Yao J, Chen Y, Li Y, Zeng Z, Lu Y and Song L (2021) Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM. Front. Oncol. 10:614430. doi: 10.3389/fonc.2020.614430
Received: 06 October 2020; Accepted: 30 November 2020;
Published: 21 January 2021; Retracted: 20 March 2024.
Edited by:
Giuseppe Giaccone, Cornell University, United StatesReviewed by:
Fabio Tavora, Federal University of Ceara, BrazilZisis Kozlakidis, International Agency For Research On Cancer (IARC), France